Aspire BioPharma, Inc. (ASBP) Ownership

$0.29

$0.01 (2.38%)
Last update: 01:00 PM EST
Day's range
$0.28
Day's range
$0.31

Aspire Biopharma Holdings, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TORONTO DOMINION BANK 05/15/2025 516.85 K $349.90 K   100.00% 6.66%
CREWE ADVISORS LLC 04/23/2025 313.43 K $182.60 K   100.00% 4.04%
HARRADEN CIRCLE INVESTMENTS, LLC 05/15/2025 150.00 K $87.39 K   100.00% 1.93%
04/18/2025 106.45 K $62.02 K   100.00% 1.37%
PROCYON ADVISORS, LLC 04/11/2025 98.50 K $57.39 K   100.00% 1.27%
PERISCOPE CAPITAL INC. 05/13/2025 75.00 K $33.75 K   100.00% 0.97%
PLATFORM TECHNOLOGY PARTNERS 05/01/2025 37.61 K $21.91 K   100.00% 0.48%
UBS GROUP AG 05/13/2025 29.95 K $17.46 K   100.00% 0.39%
TWO SIGMA SECURITIES, LLC 05/15/2025 27.41 K $15.97 K   100.00% 0.35%
CITADEL ADVISORS LLC 05/15/2025 26.90 K $15.68 K   100.00% 0.35%
JANE STREET GROUP, LLC 05/19/2025 21.02 K $12.25 K   100.00% 0.27%
VIRTU FINANCIAL LLC 05/12/2025 16.69 K $10.00 K   100.00% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 16.02 K $9.34 K   100.00% 0.21%
05/01/2025 140 $82   100.00% 0.00%
FARTHER FINANCE ADVISORS, LLC 04/14/2025 20 $12   100.00% 0.00%

Aspire Biopharma Holdings, Inc. institutional Ownership - FAQ's

During the previous two years, 13 institutional investors and hedge funds held shares of Aspire Biopharma Holdings, Inc.. The most heavily invested institutionals were:

TORONTO DOMINION BANK: 516,845

Crewe Advisors LLC: 313,427

Harraden Circle Investments, LLC: 150,000

Procyon Advisors, LLC: 98,500

PERISCOPE CAPITAL INC.: 75,000

Platform Technology Partners: 37,611

18.49% of Aspire Biopharma Holdings, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 1.33 M shares in the last 24 months. This purchase volume represents approximately $388.18 K in transactions.